Human exposure to bisphenol compounds (BPs) has been implicated in the development of several chronic diseases. Instead of exploiting the traditional methods for determination of BPs, this work confirms that the human estrogen receptor α ligand binding domain (hERα-LBD) is a powerful recognition element that can be used to monitor multi-residue of BPs in urine samples by fluorescence polarization (FP) assay. Test parameters were optimized for the best performance. Under the optimal conditions, the IC 50 values of BPs are in the range of 0.04-1.61 μg mL −1 . Recovery experiments were then performed to assess the accuracy and precision of the established method. The results detected by FP assay show good agreements with that of liquid chromatography-tandem mass spectrometry method with a fit of R 2 = 0.9372 and 0.9640 for BPE and BPAP, respectively. A computational methodology, ligand-based pharmacophore model, was also employed to further explore the broad-specific of tested compounds. It was found that the two hydrogen bond acceptor features and one hydrophobic aliphatic feature were essential for the corresponding cross-reactivity results from the FP assay. All these results suggest that the established method can be successfully applied to monitor the occurrence
Introduction
Bisphenol compounds (BPs) are organic synthetic compounds with a shared chemical structure: two phenolic rings linked via a bridging carbon [1, 2] . Bisphenol chemicals, including bisphenol A (BPA), bisphenol AP (BPAP), bisphenol S (BPS), and bisphenol E (BPE), are a class of small organic compounds widely used in plastics, food packaging, and other products. Among them, BPA is a ubiquitous industrial chemical used extensively as a high-production volume non-steroidal monomer in the plastics industry [3] . Literatures demonstrate that BPA is an endocrine disrupting compound, posing potential adverse effects on the health of wildlife and human beings. Consequently, the use of BPA in plastic containers for food and beverage has been restricted in several countries. However, other bisphenol analogs, intended to replace BPA for various industrial applications, are increasingly being used and detected in the environment [4] . Library (wileyonlinelibrary.com) Numerous studies have shown that BPs are released from consumer products, and BPs detection is foremost conducted in food and environmental system [5] . Hence, consumers are more likely exposed to BPs in their contact with food and beverage containing BPs materials [5] . Unsurprisingly, studies have identified BPs in human serum, urine, and umbilical cord blood [6] [7] [8] . Recent studies have also demonstrated the estrogenic activity, immunotoxicity, and toxicity of BPs in vitro and in vivo [6] . More importantly, BPs can potentially disturb the function of hormones in the human body, even at trace level. It is considered that such endocrine disruptor compounds could disrupt the endocrine system mainly through direct interactions with estrogen receptor (ER). ER belongs to the superfamily of nuclear receptor proteins, which includes progesterone, glucocorticoid, mineralocorticoid, and thyroid receptors [9] . Structurally, the ER consists of three domains namely N-terminal DNA-binding domain, N-terminal domain, and C-terminal LBD [10] .
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Bisphenol A and its analogues are reported to widely occur in foodstuffs, indoor dust, sewage sludge, and sediments [11] . Traditional procedures for determining BPs, such as spectroscopic [12] and immunochemical methods [13] , though sensitive, are complicated in sample extraction, time consuming and demanding for skilled personnel. Fluorescence polarization (FP) assay is founded on the exceptional specificity of antibodies for their target antigens and has been extensively employed in clinical diagnostics [14] . Nowadays, the receptor-based FP assay has already been successfully applied to the detection of ochratoxin A [15] , 17β-estradiol [16] , ractopamine [17] , and phthalate esters [18] . As a simple and rapid method, broadspecific receptor-based FP assay has several advantages, such as short assay time and absence of washing step in comparison with the enzyme-linked immunosorbent assay.
This study aims to setup a broad-specific FP method for the determination of bisphenol chemicals. The soluble form of the human ER α ligand binding domain (hERα-LBD) was expressed as a glutathione S-transferase (GST)-tagged recombinant protein in Escherichia coli, as a recognition element in this detective system. Conditions for several typical factors on the FP assay performance were optimized, and the results of FP assay were compared with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Furthermore, nine tested compounds were used to create a ligand-based pharmacophore, which was used to find the key features that are responsible for the multi-detection FP format.
Material and Methods

Reagents
Coumestrol (CS), β-Glucuronidase, 2,2-bis(4-hydroxyphenyl) propane (BPA), 2,2-bis(4-hydroxyphenyl)butane (BPB), 2,2-bis(4-hydroxy-3-methylphenyl)propane (BPC), 1,1-bis(4-hydroxyphenyl)ethane (BPE), 1,3-bis(2-(4-hydroxyphenyl)-2-propyl)benzene (BPM), 1,4-bis(2-(4-hydroxyphenyl)-2-propyl)benzene (BPP), bis (4-hydroxyphenyl)sulfone (BPS), 1,1-bis(4-hydroxyphenyl)-cyclohexane (BPZ), and 1,1-bis(4-hydroxyphenyl)-1-phenylethane (BPAP) were purchased from Sigma-Aldrich (St. Louis, MO, USA), TCI (Tokyo, Japan), and Aladdin (Shanghai, China). All other reagents used were of analytical grade.
Test procedure
The production of a broad-specify recognize element is essential for the FP assay. Briefly, hERα-LBD (residues 282-595) was expressed as a GST-tagged recombinant protein in E. coli. The whole expression and purification procedures were described in previous work by our team [19] . Of equal importance is the selection of proper concentrations of tracer and receptor that are used to format the hERα-LBD-CS complex. The optimal tracer concentration should have a fluorescence intensity that is approximately 5-10-folds the signal of background buffer. The receptor protein concentration corresponding to approximately 50% of the maximal signal was chosen as the optimum [20] . After being incubated at room temperature, the FP signal was measured by using the FlexStation 3 microplate reader (Molecular Devices, Sunnyvale, CA, USA) and the excitation and emission wavelengths are 355 and 405 nm, respectively.
Analytical parameter
The concentration of 50% inhibition was defined as IC 50 , which is the concentration of the competitor required to displace half of the initially bound ligand. The limit of detection (LOD) and detectable concentration range (IC 20 -IC 80 ) were the concentrations of BPs that inhibit tracers binding by 10% and 20%-80%, respectively. The cross-reactivity (CR) of hERα-LBD was investigated by a test of structural analogues related to BPM. The CR values were calculated based on the following formula: CR% = (IC 50 of BPM/IC 50 of bisphenol competitor) × 100%.
Sample treatment
In order to evaluate the effectiveness in obtaining accurate quantification of BPs in urine, we employed the hERα-LBDbased FP assay in fortification experiments. Because of the widespread biological effects, BPs needed to be detected in urine samples from individuals [6] . As two common bisphenol compounds in urine, BPE and BPAP, are used in the recovery test. The human urine samples were collected from a male adult volunteer without exposure to environmental BPs [21] . Urine samples were immediately centrifuged and the supernatants were stored at −20
• C before further analysis. A hydrolysis process to release free BPs in urine was accomplished based on the modified methods of Kawaguchi et al. [22] . In brief, all the urine samples were treated with the mixtures of β-glucuronidase and 1.0 M ammonium acetate (pH 6.8) by incubating at 37
• C for 2 H. Known amounts of standard BPE and BPAP were added to blank urine samples. Then the spiked samples were analyzed by the optimized FP assay. Each sample was tested with three replicates to verify repeatability.
Pharmacophore generation for BPs
Common feature-based pharmacophore models try to describe the arrangement of key features that are significant for biological activity, and their applications have been widely described [23] . Initially, the structures of BPs, consisting of two phenolic rings joined by bridging alkyl moisty, were constructed and optimized by GaussView and Gaussian program. Three highly active compounds of the tested BPs were chosen as training set compounds based on their molecular structures and experimental results. Training set selection is the most important step for the high quality of automatically generated pharmacophore models. For the training set compounds mentioned above, the parameters of principal value and maximum omit feature value were set to 2 and 0, respectively, and the default arguments were employed in the conformation generation procedure of training set. Before the generation of common feature pharmacophore model, desired chemical features were identified using feature mapping protocol. Taking the ligand flexibility into account, the ligand was indicated by a collection of conformers, which were generated using best conformer generation option [24] . For each molecule, a largest number of 250 conformers were searched with an energy threshold of 20 kcal mol −1 above the global minimum conformer. The remaining control parameters were kept at their default values. From the generated pharmacophore models, we have selected the highest-rank one, which is then used to further explain the high CR experiments results.
Method validation
LC−MS/MS was performed on UltiMate 3000 RSLC system with a Phenomenex Kinetex C18 100A column (100 mm × 2.1 mm, 2.6 μm) by using water (A) and methanol (B) as the mobile phase solvents. The flow rate was 0.4 mL/Min and the gradient elution was carried out as follows: 0 Min, 90:10; 1.5 Min, 90:10; 2 Min, 25:75; 5 Min, 25:75; 5.1 Min, 90:10; 10 Min, 90:10. A TSQ Endura triple quadrupole mass spectrometer was used to determine the analyte concentrations. The MS/MS apparatus was operated by the heated electrospray ionization (H-ESI) in negative mode. Each of the tested compounds was monitored at two transitions for quantification and confirmation. The ion source properties were: sheath gas, 30 Arb; aux gas, 5 Arb; ion transfer tube temperature, 342
• C; vaporizer temperature, 358
• C.
Results and Discussion
Optimization of the FP assay
The performance of FP assay may be influenced by several factors and the optimization process is necessary to improve the sensitivity and reproducibility. The utilization of hERα-LBD provides a versatile strategy for the development of multi-residues determination. Hence, the optimal concentrations of hERα-LBD and tracer are key parameters in the development of FP assay. To realize the features, one precondition for the sensitivity of the FP signal is whether the hERα-LBD-CS complex can be formed in the presence of competitors. Commonly, FP methods can benefit from utilizing competitors for which the receptor has slightly lower binding affinity than to the analyte. When tracer is at optimal concentration, its fluorescence intensity was about 5-10-fold of the background buffer. The tracer would have an appropriate signal and checked with the binding receptor. Therefore, this should be the optimal concentration for the tracer. The concentration of the receptor was also an essential factor for the FP assay. And the working concentration of hERα-LBD was determined by the receptor concentration giving 50% binding with the tracer. Therefore, 10 nM of tracer was selected for the following assays. Based on the optimized tracer conditions, the best concentration of hERα-LBD was 250 nM.
Analytical parameters of FP assay
The analytical performance of the hERα-LBD-based FP assay was investigated under optimized conditions. The detection limits of the current method were in the range of 0.02-0.45 μg mL −1 with sensitive performance, and BPs could be determined with the IC 50 in the range of 0.04-1.61 μg mL −1 . The working ranges of the developed FP assay were shown in Table 1 .
CR studies were performed through developed FP assay with various concentrations of competitors to complete combination with tracer for receptor binding. Our primary objective in the CR study was to determine the CR values of eight bisphenol chemicals. The secondary objective was to evaluate how well the different molecular structures affect the CR results with bisphenols-based assays. It can be noted that the CR values of tested compounds could be classified into two groups. To further elucidate the CR results of the assay, the available crystal structures of ERα complexes promises a way to understand various aspects of binding mechanism. Two different ER-based X-Ray crystal complexes, which are, a complex of ERα-LBD mutant (Y537S) and BPA, and a complex of wild-type ERα-LBD and bisphenol C (BPC), have recently been reported [25] . According to the published reports, the binding pocket shows relatively non-specific binding, which allows to hold other estrogen-like molecular [10] . Noticeable CR values were observed from Table 2 from 1,200% to 29.81%. The most estrogenic BPs contained two phenolic rings with multiple alkyl substituent groups bound to the ring-linking carbon [10] . Some BPs with minimal ring linking alkyl side chains stimulated more gene induction and proliferation activity than expected from binding determinations alone [10] . It could also be concluded that the loss of hydroxyl substituents on the main ring leaded to a sharp decrease in receptor binding ability. Furthermore, the types of substituents and lengths had considerable influence on ER specificity as well. These structural features are believed to account for the high affinity of the receptor. Taking into account the CR results that the tested molecular structures might reasonably possess crucial groups required to interact with the receptor, it could have the explanation of the broad-specificity based FP assay format. Although the selectivity of this method for a certain BP is relatively lower than that of chromatographic analysis, the most advantage of receptor assay is multi-residues detection. In the future work, the pretreatment process will be optimized to improve the sensitivity of FP assay. 
Analysis of spiked samples
Much data showed that BPE and BPAP that possesses light to moderate acute toxicity and weak estrogenicity like BPA have already been found in human urine and serum. In response to these restrictions and public concern, the monitoring level of bisphenol analogs should be improved. In order to check the accuracy, recovery assays were performed by spiking with BPE and BPAP to urine samples at three concentration levels, which corresponded to the low, intermediate, and high concentrations of the linearity range. Obtained recoveries averaged between 98.33% and 108.89% with CV from 7.02% to 10.75% (Table 3) . Both the accuracy and precision were considered good for all fortification levels, indicating that the proposed method was feasible for the analysis of BPs in urine samples.
Common feature pharmacophore model
Common feature-based pharmacophore modeling is built with a set of highly active of molecular considering their chemical groups as chemically important components for their activity. All the generated pharmacophore models based on experimental evaluations had similar pharmacophoric features. In this analysis, the first hypothesis has shown highly mapping ability values and thus was selected as the best model. The generated pharmacophore derived from nine tested molecules consisted of two hydrogen bond acceptor features and a hydrophobic aliphatic feature (Fig. 1) . Apparently, the hydrogen bonding and hydrophobic interactions were significant for ERα affinity, which was consistent with the results of previous experimental analysis [26] . The molecule structures and their interactions with the pharmacophore can be visualized to further understand how feature mapping relates to CR results. Apparently, the size of BPS was smaller than other tested ligands, therefore, BPS only mapped two out of three features, missing the hydrophobic aliphatic feature. This would also be deduced that this compound is likely to reduce affinity compared with BPZ and BPB, but the two hydrogen bond acceptor features help the BPS maintain intermolecular forces with hERα-LBD. Overall, the two hydrogen bond acceptor
FIG. 1
The features and one hydrophobic aliphatic feature of the best pharmacophore could properly interpret the high CR values of the experimental results. In conclusion, the ligand-based pharmacophore model can potentially be applied for predicting the receptor-binding properties of other compounds based on their molecular structure.
FIG. 2
Correlation between fluorescence polarization (FP) assay and LC−MS/MS for spiked urine samples.
Validation of the assay with the conventional method
With the selected parameters described above, the reporting method was further validated by LC−MS/MS. Known concentrations of urine samples were measured by LC−MS/MS and the developed FP assay simultaneously. The results are shown in Fig. 2 . The results detected by the FP assay showed good agreement with that of LC−MS/MS with a fit of R 2 = 0.9372 and 0.9640 for BPE and BPAP, suggesting that the FP assay could be a simple and accurate method for detection of BPs in urine. Considering that the real samples may contain more than one BP, receptor-based FP assay is favorable to be used as a screening method to detect the total quantity of BPs.
Conclusions
Instead of exploiting the specificity of antibodies for their target antigens, the study focuses on hERα-LBD and confirms that it is a powerful tool to recognize several BPs and it allows optimizing extremely simple and efficient assays with minimal technical requirements. This study establishes an effective method to monitor the levels of bisphenols using hERα-LBD-CS complex as a bio-recognition element. The proposed method shows satisfactory precision and good sensitivity for the test compounds. The reproducibility and recovery of the proposed method were satisfactory. Based on the generation of 3D pharmacophore model, the two hydrogen bond acceptor features and one hydrophobic aliphatic feature of tested bisphenols could associate with the binding activity and high CR values. In addition, the detection data of FP assay in urine were compared with those of LC−MS/MS. These results indicated that the proposed receptor-based FP assay is reliable and has great potential for determination of trace amounts of BPs in the biological monitor.
